Insight Brief
Optimizing Doses for Combination Therapies in Oncology
Integrating best practices and regulatory expectations to streamline development
Oct 21, 2025
This insight brief from IQVIA's oncology experts highlights how model-informed strategies and FDA guidance are reshaping dose optimization for combination therapies. Learn how integrating best practices and regulatory expectations can streamline development, improve efficacy, and reduce toxicity, helping to bring treatments to those in need, faster.

Related solutions

Contact Us